Interpace Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 35.2% | 35.2% | -38.9% |
| FY2022 | 37.8% | 37.8% | -137.4% |
| FY2023 | -3.5% | -3.5% | 14.9% |
| FY2024 | -302.3% | -302.3% | 45.3% |
| FY2025 | 109.9% | 109.9% | 72.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 35.2% | 35.2% | -38.9% |
| FY2022 | 37.8% | 37.8% | -137.4% |
| FY2023 | -3.5% | -3.5% | 14.9% |
| FY2024 | -302.3% | -302.3% | 45.3% |
| FY2025 | 109.9% | 109.9% | 72.6% |